Research is uncovering exciting potential benefits in other areas: Important note: These off-label or experimental uses are not yet FDA-approved
How Its Administered Subcutaneous (SubQ): Injected into belly fat or a fatty tissue area for systemic distribution Intramuscular (IM): Injected directly into or near an injured muscle or tendon for localized healing Dosage: Typically 250500 mcg daily, often split into two doses depending on severity Injectable BPC157 is typically sold as a lyophilized powder, reconstituted with bacteriostatic water and drawn into an insulin syringe for injection
Whilst nausea is common with GLP-1 drugs, severe or prolonged symptoms may indicate gastroparesis (severely delayed gastric emptying) or other complications
Prunty A, Clark MK, Hahn A, Edmonds S, OShea A
BMC Public Health 17 , 683 (2017)
If statins in some people nudge glucose up (possibly via lower GLP-1), that metabolic effect could, indirectly, be unfavorable for the brain